Peter Neumann
@peterneumann11.bsky.social
From QALYs to Equal Value Life Years: Is Anyone Making the Shift? Some thoughts with Antony Martin.
cevr.tuftsmedicalcenter.org/news/from-qa... @tuftscevr.bsky.social #HEOR #QALYs
cevr.tuftsmedicalcenter.org/news/from-qa... @tuftscevr.bsky.social #HEOR #QALYs
From QALYs to Equal Value Life Years: Is Anyone Making the Shift? - Center for the Evaluation of Value and Risk in Health
cevr.tuftsmedicalcenter.org
October 16, 2025 at 12:49 PM
From QALYs to Equal Value Life Years: Is Anyone Making the Shift? Some thoughts with Antony Martin.
cevr.tuftsmedicalcenter.org/news/from-qa... @tuftscevr.bsky.social #HEOR #QALYs
cevr.tuftsmedicalcenter.org/news/from-qa... @tuftscevr.bsky.social #HEOR #QALYs
Our new research letter in JAMA, led by James Chambers, highlights variation in how US commercial health plans impose coverage requirements for cell & #gene therapies.
jamanetwork.com/journals/jam... @tuftscevr.bsky.social
jamanetwork.com/journals/jam... @tuftscevr.bsky.social
Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies
This Viewpoint examines variations in US commercial health plan coverage restrictions for cell and gene therapies.
jamanetwork.com
September 29, 2025 at 9:22 PM
Our new research letter in JAMA, led by James Chambers, highlights variation in how US commercial health plans impose coverage requirements for cell & #gene therapies.
jamanetwork.com/journals/jam... @tuftscevr.bsky.social
jamanetwork.com/journals/jam... @tuftscevr.bsky.social
Pleased to join this distinguished group of authors in paying tribute to the great John Iglehart, founding editor of Health Affairs, who passed away in June.
tinyurl.com/47rnt9yf @tuftscevr.bsky.social @healthaffairs.bsky.social
tinyurl.com/47rnt9yf @tuftscevr.bsky.social @healthaffairs.bsky.social
Remembering John Iglehart, <i>Health Affairs</i> Founding Editor | Health Affairs Forefront
In this piece, we present remembrances of John from several of the countless people whose lives John touched personally and professionally.
tinyurl.com
September 24, 2025 at 12:31 PM
Pleased to join this distinguished group of authors in paying tribute to the great John Iglehart, founding editor of Health Affairs, who passed away in June.
tinyurl.com/47rnt9yf @tuftscevr.bsky.social @healthaffairs.bsky.social
tinyurl.com/47rnt9yf @tuftscevr.bsky.social @healthaffairs.bsky.social
New Tufts-CEVR research led by @pattysynnott.bsky.social highlights:
- high out-of-pocket costs of older adults living with dementia
- financial risks increase in advanced dementia states.
alz-journals.onlinelibrary.wiley.com/doi/10.1002/... #Alzheimers #dementia
- high out-of-pocket costs of older adults living with dementia
- financial risks increase in advanced dementia states.
alz-journals.onlinelibrary.wiley.com/doi/10.1002/... #Alzheimers #dementia
Characterizing financial risk from out‐of‐pocket expenditures across dementia stages
INTRODUCTION Older adults with dementia incur considerable out-of-pocket (OOP) health care expenses, but it is unclear how their financial burden differs by dementia stage. METHODS We identified 2...
alz-journals.onlinelibrary.wiley.com
September 22, 2025 at 12:41 PM
New Tufts-CEVR research led by @pattysynnott.bsky.social highlights:
- high out-of-pocket costs of older adults living with dementia
- financial risks increase in advanced dementia states.
alz-journals.onlinelibrary.wiley.com/doi/10.1002/... #Alzheimers #dementia
- high out-of-pocket costs of older adults living with dementia
- financial risks increase in advanced dementia states.
alz-journals.onlinelibrary.wiley.com/doi/10.1002/... #Alzheimers #dementia
In this just published paper in Value in Health led by Feng Xie and colleagues, we reviewed the published cost-effectiveness evidence for the 15 drugs selected for IPAY 2027 Medicare negotiations.
@djvanness.bsky.social @ankurfactorial.bsky.social
www.valueinhealthjournal.com/article/S109...
@djvanness.bsky.social @ankurfactorial.bsky.social
www.valueinhealthjournal.com/article/S109...
Cost Effectiveness of the 15 Drugs Selected for IPAY 2027 CMS Drug Price Negotiation
To analyze published cost-effectiveness analyses (CEAs) for the 15 drugs selected
for the Initial Price Applicability Year 2027 by the Centers for Medicare and Medicaid
Services (CMS).
www.valueinhealthjournal.com
September 13, 2025 at 2:16 PM
In this just published paper in Value in Health led by Feng Xie and colleagues, we reviewed the published cost-effectiveness evidence for the 15 drugs selected for IPAY 2027 Medicare negotiations.
@djvanness.bsky.social @ankurfactorial.bsky.social
www.valueinhealthjournal.com/article/S109...
@djvanness.bsky.social @ankurfactorial.bsky.social
www.valueinhealthjournal.com/article/S109...
Reposted by Peter Neumann
@icer-review.bsky.social @tuftscevr.bsky.social @peterneumann11.bsky.social @pattysynnott.bsky.social
New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...
www.healthaffairs.org/doi/10.1377/...
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
www.healthaffairs.org
August 4, 2025 at 9:10 PM
Welcome, Dave!
CEVR is thrilled to welcome David Strutton, PhD, as a Senior Fellow! Dr. Strutton brings 30+ years of global leadership in health policy, biopharma, and HTA. His expertise in real-world evidence and access strategy will be a tremendous asset.
Read more at: tinyurl.com/3bz9te3p
Read more at: tinyurl.com/3bz9te3p
David Strutton, PhD, to Join Tufts-CEVR as Senior Fellow - Center for the Evaluation of Value and Risk in Health
tinyurl.com
July 29, 2025 at 4:33 PM
Welcome, Dave!
Reposted by Peter Neumann
CEVR is thrilled to welcome David Strutton, PhD, as a Senior Fellow! Dr. Strutton brings 30+ years of global leadership in health policy, biopharma, and HTA. His expertise in real-world evidence and access strategy will be a tremendous asset.
Read more at: tinyurl.com/3bz9te3p
Read more at: tinyurl.com/3bz9te3p
David Strutton, PhD, to Join Tufts-CEVR as Senior Fellow - Center for the Evaluation of Value and Risk in Health
tinyurl.com
July 29, 2025 at 1:35 PM
CEVR is thrilled to welcome David Strutton, PhD, as a Senior Fellow! Dr. Strutton brings 30+ years of global leadership in health policy, biopharma, and HTA. His expertise in real-world evidence and access strategy will be a tremendous asset.
Read more at: tinyurl.com/3bz9te3p
Read more at: tinyurl.com/3bz9te3p
Excited to announce that David Strutton, Ph.D., a distinguished leader in healthcare policy, biopharmaceuticals, #vaccines, and #healtheconomics is joining Tufts-CEVR as a Senior Fellow.
Announcement here: cevr.tuftsmedicalcenter.org/news/david-s... @tuftscevr.bsky.social
Announcement here: cevr.tuftsmedicalcenter.org/news/david-s... @tuftscevr.bsky.social
July 29, 2025 at 2:41 PM
Excited to announce that David Strutton, Ph.D., a distinguished leader in healthcare policy, biopharmaceuticals, #vaccines, and #healtheconomics is joining Tufts-CEVR as a Senior Fellow.
Announcement here: cevr.tuftsmedicalcenter.org/news/david-s... @tuftscevr.bsky.social
Announcement here: cevr.tuftsmedicalcenter.org/news/david-s... @tuftscevr.bsky.social
Reposted by Peter Neumann
Great application of our CEA Registry at the #Vanderbilt Center for Health Economic Modeling: 11 international fellows from #LMICs used the Registry to conduct CEAs of public health interventions.
Read more at: tinyurl.com/88varaue
@peterneumann11.bsky.social #ISPOR
Read more at: tinyurl.com/88varaue
@peterneumann11.bsky.social #ISPOR
VUMC researchers host international fellows for economic evaluation, decision science training
Vanderbilt recently hosted 11 international fellows to provide training to help them address public health issues in their home countries.
tinyurl.com
July 23, 2025 at 8:12 PM
Great application of our CEA Registry at the #Vanderbilt Center for Health Economic Modeling: 11 international fellows from #LMICs used the Registry to conduct CEAs of public health interventions.
Read more at: tinyurl.com/88varaue
@peterneumann11.bsky.social #ISPOR
Read more at: tinyurl.com/88varaue
@peterneumann11.bsky.social #ISPOR
Reposted by Peter Neumann
New in JCER: CEVR’s Meng Li and @peterneumann11.bsky.social call for more value assessment of health services/procedures. These interventions are ~70% of health care spending but are often implemented without robust evidence and, unlike drugs, can cost more over time.
Read: tinyurl.com/ycxrppby
Read: tinyurl.com/ycxrppby
Value assessment for health services and procedures: a call to action in a new political climate
tinyurl.com
July 21, 2025 at 4:32 PM
New in JCER: CEVR’s Meng Li and @peterneumann11.bsky.social call for more value assessment of health services/procedures. These interventions are ~70% of health care spending but are often implemented without robust evidence and, unlike drugs, can cost more over time.
Read: tinyurl.com/ycxrppby
Read: tinyurl.com/ycxrppby
Reposted by Peter Neumann
Two weeks left to apply: Earn your #HEOR Certificate online from @tufts.edu with globally-recognized faculty like @peterneumann11.bsky.social, @dano-hta.bsky.social, James Chambers, and more from CEVR. Apply today!
Deadline is Aug. 1.
tinyurl.com/pr6drkhf
#RWE #pharma
Deadline is Aug. 1.
tinyurl.com/pr6drkhf
#RWE #pharma
Health Economics and Outcomes Research (HEOR) Certificate Program - Tufts CTSI
Overview The Tufts University Graduate School of Biomedical Sciences (GSBS) Clinical and Translational Science (CTS) Graduate Program is delighted to offer an accredited Certificate Program in Health ...
tinyurl.com
July 18, 2025 at 6:13 PM
Two weeks left to apply: Earn your #HEOR Certificate online from @tufts.edu with globally-recognized faculty like @peterneumann11.bsky.social, @dano-hta.bsky.social, James Chambers, and more from CEVR. Apply today!
Deadline is Aug. 1.
tinyurl.com/pr6drkhf
#RWE #pharma
Deadline is Aug. 1.
tinyurl.com/pr6drkhf
#RWE #pharma
Reposted by Peter Neumann
Larry Mose, MSc is today’s #CEARegistry Summer fellow. Larry earned his MSc from @york.ac.uk and hopes to work in the field of #HEOR.
Our thanks to the @moorefound.bsky.social for funding the CEA Registry Fellowship program!
Our thanks to the @moorefound.bsky.social for funding the CEA Registry Fellowship program!
July 14, 2025 at 5:13 PM
Larry Mose, MSc is today’s #CEARegistry Summer fellow. Larry earned his MSc from @york.ac.uk and hopes to work in the field of #HEOR.
Our thanks to the @moorefound.bsky.social for funding the CEA Registry Fellowship program!
Our thanks to the @moorefound.bsky.social for funding the CEA Registry Fellowship program!
Reposted by Peter Neumann
1/ How closely do health plans’ drug #utilizationmanagement (UM) policies align with #clinicalguidelines? CEVR and NPC examined policies for 389 drug-indication pairs from 18 commercial insurers. Here’s a thread on what we found:
July 7, 2025 at 8:18 PM
1/ How closely do health plans’ drug #utilizationmanagement (UM) policies align with #clinicalguidelines? CEVR and NPC examined policies for 389 drug-indication pairs from 18 commercial insurers. Here’s a thread on what we found:
Some personal reflections about John Iglehart (1939-1975), Founding Editor of Health Affairs.
cevr.tuftsmedicalcenter.org/news/in-reme... @tuftscevr.bsky.social
cevr.tuftsmedicalcenter.org/news/in-reme... @tuftscevr.bsky.social
In remembrance of John Iglehart - Center for the Evaluation of Value and Risk in Health
cevr.tuftsmedicalcenter.org
June 23, 2025 at 1:11 PM
Some personal reflections about John Iglehart (1939-1975), Founding Editor of Health Affairs.
cevr.tuftsmedicalcenter.org/news/in-reme... @tuftscevr.bsky.social
cevr.tuftsmedicalcenter.org/news/in-reme... @tuftscevr.bsky.social
New Tufts-CEVR paper in the J of Alzheimer's Disease, led by Paige Lin, provides updated health utility estimates for persons with AD and their caregivers across disease stages and settings.
journals.sagepub.com/doi/10.1177/... @tuftscevr.bsky.social @pattysynnott.bsky.social #Alzheimers
journals.sagepub.com/doi/10.1177/... @tuftscevr.bsky.social @pattysynnott.bsky.social #Alzheimers
June 20, 2025 at 3:47 PM
New Tufts-CEVR paper in the J of Alzheimer's Disease, led by Paige Lin, provides updated health utility estimates for persons with AD and their caregivers across disease stages and settings.
journals.sagepub.com/doi/10.1177/... @tuftscevr.bsky.social @pattysynnott.bsky.social #Alzheimers
journals.sagepub.com/doi/10.1177/... @tuftscevr.bsky.social @pattysynnott.bsky.social #Alzheimers
Pleased to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, supported by the Gordon and Betty Moore Foundation.
cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social
cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social
CEVR Welcomes 2025 CEA Registry Summer Fellows - Center for the Evaluation of Value and Risk in Health
cevr.tuftsmedicalcenter.org
June 17, 2025 at 5:27 PM
Pleased to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, supported by the Gordon and Betty Moore Foundation.
cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social
cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social
Reposted by Peter Neumann
CEVR is thrilled to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, which is supported by the @moorefound.bsky.social. Stay tuned over the next two months for featured posts about each fellow!
More details at: cevr.tuftsmedicalcenter.org/news/2025-ce...
More details at: cevr.tuftsmedicalcenter.org/news/2025-ce...
CEVR Welcomes 2025 CEA Registry Summer Fellows - Center for the Evaluation of Value and Risk in Health
cevr.tuftsmedicalcenter.org
June 16, 2025 at 5:43 PM
CEVR is thrilled to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, which is supported by the @moorefound.bsky.social. Stay tuned over the next two months for featured posts about each fellow!
More details at: cevr.tuftsmedicalcenter.org/news/2025-ce...
More details at: cevr.tuftsmedicalcenter.org/news/2025-ce...
Congrats, Mel!
In recognition of her expertise in health economics, CEVR Senior Fellow Melanie Whittington, PhD, has been appointed to the Congressional Budget Office (#CBO) 2025 Panel of Health Advisors. Congratulations Melanie!
Read the CBO announcement at tinyurl.com/ms7j82c6
Read the CBO announcement at tinyurl.com/ms7j82c6
CBO’s Panel of Health Advisers, 2025
CBO announces the members of its Panel of Health Advisers for the coming year.
tinyurl.com
June 7, 2025 at 3:02 PM
Congrats, Mel!
Reposted by Peter Neumann
New in Value in Health: three former CEA Registry Summer Fellows (Xujun Gu, Hanwen Zhang, and Divya Patil) and U of Maryland's Julia Slejko used the CEA Registry to explore the utility of AI-assisted data extraction.
Read at tinyurl.com/37mh5n6m
Read at tinyurl.com/37mh5n6m
Use of Large Language Models to Extract Cost-Effectiveness Analysis Data: A Case Study
Cost-effectiveness analyses (CEAs) generate extensive data that can support much health
economic research. However, manual data collection is time-consuming and prone to
errors. Development in Artific...
tinyurl.com
June 6, 2025 at 3:20 PM
New in Value in Health: three former CEA Registry Summer Fellows (Xujun Gu, Hanwen Zhang, and Divya Patil) and U of Maryland's Julia Slejko used the CEA Registry to explore the utility of AI-assisted data extraction.
Read at tinyurl.com/37mh5n6m
Read at tinyurl.com/37mh5n6m
Reposted by Peter Neumann
ISPOR and CEVR are partnering to offer free premium access to the CEA Registry for students + academic/government researchers in LMICs.
Unlock data from 14,000+ cost-effectiveness studies, advanced tools, and more.
More at: tinyurl.com/5y3vpsz3
#HEOR #GlobalHealth #ISPOR
Unlock data from 14,000+ cost-effectiveness studies, advanced tools, and more.
More at: tinyurl.com/5y3vpsz3
#HEOR #GlobalHealth #ISPOR
Research Ideas for CEA Registry Users - Center for the Evaluation of Value and Risk in Health
tinyurl.com
May 29, 2025 at 1:42 PM
ISPOR and CEVR are partnering to offer free premium access to the CEA Registry for students + academic/government researchers in LMICs.
Unlock data from 14,000+ cost-effectiveness studies, advanced tools, and more.
More at: tinyurl.com/5y3vpsz3
#HEOR #GlobalHealth #ISPOR
Unlock data from 14,000+ cost-effectiveness studies, advanced tools, and more.
More at: tinyurl.com/5y3vpsz3
#HEOR #GlobalHealth #ISPOR
We're excited to announce Tufts-CEVR's new partnership with ISPOR to provide free, premium access to the CEA Registry for ISPOR members who are students or researchers in LMICs.
More detail here: cevr.tuftsmedicalcenter.org/news/cevr-is...
@djvanness.bsky.social @tuftscevr.bsky.social
More detail here: cevr.tuftsmedicalcenter.org/news/cevr-is...
@djvanness.bsky.social @tuftscevr.bsky.social
ISPOR Student and LMIC Researcher Members to Receive Free CEA Registry Access under Tufts-CEVR / ISPOR Partnership - Center for the Evaluation of Value and Risk in Health
cevr.tuftsmedicalcenter.org
May 29, 2025 at 2:17 PM
We're excited to announce Tufts-CEVR's new partnership with ISPOR to provide free, premium access to the CEA Registry for ISPOR members who are students or researchers in LMICs.
More detail here: cevr.tuftsmedicalcenter.org/news/cevr-is...
@djvanness.bsky.social @tuftscevr.bsky.social
More detail here: cevr.tuftsmedicalcenter.org/news/cevr-is...
@djvanness.bsky.social @tuftscevr.bsky.social
With @tuftscevr.bsky.social colleagues #ISPORAnnual in Montreal.
May 14, 2025 at 6:18 PM
With @tuftscevr.bsky.social colleagues #ISPORAnnual in Montreal.
Thanks to all my wonderful Tufts-CEVR colleagues for putting on another great annual meeting! Proud to work with you!
@dano-hta.bsky.social @brianreid.bsky.social @tuftscevr.bsky.social @mollytoba.bsky.social
@dano-hta.bsky.social @brianreid.bsky.social @tuftscevr.bsky.social @mollytoba.bsky.social
April 19, 2025 at 3:10 PM
Thanks to all my wonderful Tufts-CEVR colleagues for putting on another great annual meeting! Proud to work with you!
@dano-hta.bsky.social @brianreid.bsky.social @tuftscevr.bsky.social @mollytoba.bsky.social
@dano-hta.bsky.social @brianreid.bsky.social @tuftscevr.bsky.social @mollytoba.bsky.social
Congrats!
CEVR is thrilled to announce the winners of our 7th Annual Cost-Effectiveness Paper of the Year Award.
Best CEA — Anita Brogan et al. Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States (tinyurl.com/mw5ff646)
#CEA #HEOR
Best CEA — Anita Brogan et al. Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States (tinyurl.com/mw5ff646)
#CEA #HEOR
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States - PharmacoEconomics
Objective Cabotegravir long-acting (CAB–LA) administered every 2 months was approved in the USA as pre-exposure prophylaxis (PrEP) for individuals at risk of acquiring human immunodeficiency virus (HI...
tinyurl.com
April 9, 2025 at 8:45 PM
Congrats!